These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. The Clinical Implication of Incidental Epidermodysplasia Verruciformis. Borretta LJ; Kirchhof MG; Crawford RI Am J Dermatopathol; 2021 Feb; 43(2):156-158. PubMed ID: 32649343 [No Abstract] [Full Text] [Related]
7. Epidermodysplasia verruciformis: immunological and clinical aspects. Jablonska S; Majewski S Curr Top Microbiol Immunol; 1994; 186():157-75. PubMed ID: 8205840 [No Abstract] [Full Text] [Related]
8. Epidermodysplasia verruciformis. Hafeez ZH; Thawerani H J Pak Med Assoc; 1996 Dec; 46(12):282-4. PubMed ID: 9000832 [No Abstract] [Full Text] [Related]
9. Cutaneous squamous cell carcinoma with epidermodysplasia verruciformis-like features in a patient with Schimke immune-osseous dysplasia. Collins MK; Peters K; English JC; Rady P; Tyring S; Jedrych J J Cutan Pathol; 2018 Jun; 45(6):465-467. PubMed ID: 29498428 [No Abstract] [Full Text] [Related]
10. A case of epidermodysplasia verruciformis (EV) with human papillomavirus 16 (HPV16) DNA detected in the skin lesions: can HPV16 infect patients with EV? Hayashi S; Hatamochi A; Soutome A; Hamasaki Y; Yamazaki S; Kawase M; Tadano M; Kitasato H Int J Dermatol; 2011 Sep; 50(9):1168-70. PubMed ID: 22126886 [No Abstract] [Full Text] [Related]
11. Mutation and abnormal expression of the p53 gene in the viral skin carcinogenesis of epidermodysplasia verruciformis. Padlewska K; Ramoz N; Cassonnet P; Riou G; Barrois M; Majewski S; Croissant O; Jablonska S; Orth G J Invest Dermatol; 2001 Oct; 117(4):935-42. PubMed ID: 11676835 [TBL] [Abstract][Full Text] [Related]
12. Why epidermodysplasia verruciformis - a rare genetic disease - has raised such great interest. Majewski S; Jablonska S Int J Dermatol; 2004 Apr; 43(4):309-11. PubMed ID: 15090022 [No Abstract] [Full Text] [Related]
13. A novel human papillomavirus identified in epidermodysplasia verruciformis. Harris AJ; Purdie K; Leigh IM; Proby C; Burge S Br J Dermatol; 1997 Apr; 136(4):587-91. PubMed ID: 9155964 [TBL] [Abstract][Full Text] [Related]
14. A novel EVER1 gene mutation associated with epidermodysplasia verruciformis and multiple cutaneous malignancies. Kim NY; Cheon DU; Joh HC; Kim JE J Eur Acad Dermatol Venereol; 2023 Apr; 37(4):e524-e526. PubMed ID: 36268689 [No Abstract] [Full Text] [Related]
15. Skin cancer in epidermodysplasia verruciformis patients from Brazil. Oliveira WR; Rady PL; Festa C; Rivitti EA; Tyring SK J Eur Acad Dermatol Venereol; 2006 Oct; 20(9):1154-6. PubMed ID: 16987289 [No Abstract] [Full Text] [Related]
16. Squamous Cell Carcinoma Arising From Epidermodysplasia Verruciformis. Hou H; Feng L J Cutan Med Surg; 2024; 28(4):412. PubMed ID: 38323584 [No Abstract] [Full Text] [Related]
17. Perianal warts and the development of squamous cell carcinoma in epidermodysplasia verruciformis. Kivanc-Altunay I; Erdogan HK; Kayaoglu S Indian J Dermatol Venereol Leprol; 2011; 77(1):112. PubMed ID: 21220907 [No Abstract] [Full Text] [Related]
18. Antigen presentation and T-cell activation in epidermodysplasia verruciformis. Cooper KD; Androphy EJ; Lowy D; Katz SI J Invest Dermatol; 1990 Jun; 94(6):769-76. PubMed ID: 2162366 [TBL] [Abstract][Full Text] [Related]